骨セメント - 世界市場の考察、競合情勢、市場予測（2030年）

世界の骨セメントの市場規模は、2023年に8億9,486万米ドル、2030年までに12億4,731万米ドルに達し、2024年～2030年の予測期間にCAGRで5.73％の成長が見込まれます。市場は、骨折の増加につながる骨粗しょう症の有病率の上昇などの要因によって活況を示す見込みです。さらに、過去10年間における人工関節置換術の増加が骨セメント産業の市場成長に拍車をかけています。老年人口の増加も、予測期間（2024年～2030年）における骨セメント市場の大きな収益成長につながる要因の1つです。

骨セメントの市場力学

骨セメント市場の主な促進要因の1つは、骨粗しょう症の有病率の上昇です。骨粗しょう症は、骨密度が低下して骨が弱くなる疾患です。骨粗しょう症になると、ちょっとした転倒や咳やくしゃみでも頻繁に骨折するようになります。骨粗しょう症の有病率の増加による骨折率の上昇が、骨セメント市場の成長につながっています。

International Osteoporosis Foundationが発表したデータによると、骨粗しょう症が原因で世界中で年間890万件以上の骨折が起きています。2019年に、欧州全体で、50歳の3,200万人が骨粗しょう症に罹患していると推定され、これは50歳以上の欧州の総人口の5.6％に相当し、女性は約2,550万人（50歳以上の女性の22.1％）、男性は約650万人（50歳以上の男性の6.6％）です。さらに、同資料によれば、2050年までに全世界の股関節骨折の罹患率は、1990年の罹患率と比較して、男性で310％、女性で240％増加すると予測されています。

このように、男女ともに骨粗しょう症の罹患率が増加しており、骨セメントの需要が増加しています。

さらに、老年人口の増加が骨セメント市場の必要性をさらに高めています。高齢になると、筋力が弱まり骨がもろくなるため、骨折の可能性が何倍にも高まるためです。

WHOによると、2050年までに世界の60歳以上の人口は約21億人に倍増します。また、80歳以上の高齢者数は2020年～2050年に3倍の4億2,600万人に達すると予測されており、2024年～2030年の予測期間における骨セメント市場の成長に拍車をかけています。

さらに、過去数十年にわたる人工関節置換術の増加が骨セメント市場の需要を高めています。経済協力開発機構（OECD）の分析によると、OECD諸国の人工股関節置換率は2009年～2019年に平均22％増加し、人工膝関節置換率は35％増加しました。これは、OECD諸国における高齢化と肥満率の増加によって引き起こされる変形性関節症の罹患率と有病率の上昇と一致しています。したがって、2024年～2030年の予測期間における骨セメント市場の成長を促進しています。

COVID-19は骨セメント市場に悪影響を及ぼしています。ソーシャルディスタンスにより、多くの病院が非選択的処置や手術の実施を制限されました。さらに、パンデミック中、ICUの病床はCOVID-19に感染した患者で占められました。2022年に発表された「A Nation-Wide Review of Elective Surgery and COVID-Surge Capacity」と題する調査研究によると、2020年に、選択的手術の実施件数が基準値から91％減少しており、米国では手術用ICUの78％の病床がCOVID-19陽性患者のために利用できるようになっています。

さらに、交通事故の件数も世界中で減少しました。たとえば米国では、ほとんどの州の住民が自宅待機を余儀なくされたCOVID-19パンデミック初期の2ヵ月間に、交通事故がほぼ半減しました。交通事故の減少は外傷症例の減少の指標となります。したがって、このような事実から、骨セメントは事故患者の治療に使用されるため、パンデミック期間には市場の成長が鈍化していたことがわかります。しかし、多くの人々が予防接種を受け、世界のほとんどの地域でロックダウン規制が解除されたことから、市場は平常を取り戻すと予測されます。

当レポートでは、世界の骨セメント市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 骨セメント市場レポートのイントロダクション

第2章 骨セメント市場のエグゼクティブサマリー

• 調査範囲
• 市場の概要
• 競争力の評価

第3章 骨セメント市場の主な要因の分析

• 骨セメント市場の促進要因
• 骨セメント市場の抑制要因と課題
• 骨セメント市場の機会

第4章 骨セメント市場のポーターのファイブフォース分析

第5章 骨セメント市場に対するCOVID-19の影響分析

第6章 骨セメント市場情勢

• 製品タイプ
  • ポリメチルメタクリレートセメント
  • ガラスポリアルケノエートセメント
  • リン酸カルシウムセメント
• 関節別
  • 膝
  • 股関節
  • 肩
  • 脊椎
  • その他
• 手術タイプ別
  • 人工関節置換術
  • 椎体形成術
  • 椎骨形成術
• エンドユーザー別
  • 病院
  • 外来手術センター
• 地域
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第7章 骨セメント市場の企業と製品のプロファイル

• Stryker Corporation
• Zimmer Biomet
• DePuy Synthes (Johnson & Johnson)
• Smith & Nephew plc
• DJO Global
• Arthrex Inc
• Exactech
• Heraeus Holding
• Cardinal Health
• Tecres S.p.A
• Teknimed
• Amplitude
• Bioceramed
• BM Korea
• Linacol Medical

第8章 KOLの見解

第9章 プロジェクトアプローチ

第10章 DelveInsightについて

第11章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: COVID-19 Impact Analysis on Bone cement Market
• Table 3: Bone Cement Market in Global (2021-2030)
• Table 4: Bone Cement Market in Global by Product Type (2021-2030)
• Table 5: Bone Cement Market in Global by Joints (2021-2030)
• Table 6: Bone Cement Market in Global by Procedure Type (2021-2030)
• Table 7: Bone Cement Market in Global by End User (2021-2030)
• Table 8: Bone Cement Market in Global by Geography (2021-2030)
• Table 9: Bone Cement Market in North America (2021-2030)
• Table 10: Bone Cement Market in North America by Country (2021-2030)
• Table 11: Bone Cement Market in the US (2021-2030)
• Table 12: Bone Cement Market in Canada (2021-2030)
• Table 13: Bone Cement Market in Mexico (2021-2030)
• Table 14: Bone Cement Market in Europe (2021-2030)
• Table 15: Bone Cement Market in Europe by Country (2021-2030)
• Table 16: Bone Cement Market in France (2021-2030)
• Table 17: Bone Cement Market in Germany (2021-2030)
• Table 18: Bone Cement Market in the United Kingdom (2021-2030)
• Table 19: Bone Cement Market in Italy (2021-2030)
• Table 20: Bone Cement Market in Spain (2021-2030)
• Table 21: Bone Cement Market in Rest of Europe (2021-2030)
• Table 22: Bone Cement Market in APAC (2021-2030)
• Table 23: Bone Cement Market in APAC by Country (2021-2030)
• Table 24: Bone Cement Market in China (2021-2030)
• Table 25: Bone Cement Market in Japan (2021-2030)
• Table 26: Bone Cement Market in India (2021-2030)
• Table 27: Bone Cement Market in Australia (2021-2030)
• Table 28: Bone Cement Market in South Korea (2021-2030)
• Table 29: Bone Cement Market in Rest of APAC (2021-2030)
• Table 30: Bone Cement Market in Rest of World (2021-2030)
• Table 31: Bone Cement Market in RoW by Region (2021-2030)
• Table 32: Bone Cement Market in Middle East (2021-2030)
• Table 33: Bone Cement Market in Africa (2021-2030)
• Table 34: Bone Cement Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: COVID-19 Impact Analysis on Bone cement Market
• Figure 3: Bone Cement Market in Global (2021-2030)
• Figure 4: Bone Cement Market in Global by Product Type (2021-2030)
• Figure 5: Bone Cement Market in Global by Joints (2021-2030)
• Figure 6: Bone Cement Market in Global by Procedure Type (2021-2030)
• Figure 7: Bone Cement Market in Global by End User (2021-2030)
• Figure 8: Bone Cement Market in Global by Geography (2021-2030)
• Figure 9: Bone Cement Market in North America (2021-2030)
• Figure 10: Bone Cement Market in North America by Country (2021-2030)
• Figure 11: Bone Cement Market in the US (2021-2030)
• Figure 12: Bone Cement Market in Canada (2021-2030)
• Figure 13: Bone Cement Market in Mexico (2021-2030)
• Figure 14: Bone Cement Market in Europe (2021-2030)
• Figure 15: Bone Cement Market in Europe by Country (2021-2030)
• Figure 16: Bone Cement Market in France (2021-2030)
• Figure 17: Bone Cement Market in Germany (2021-2030)
• Figure 18: Bone Cement Market in the United Kingdom (2021-2030)
• Figure 19: Bone Cement Market in Italy (2021-2030)
• Figure 20: Bone Cement Market in Spain (2021-2030)
• Figure 21: Bone Cement Market in Rest of Europe (2021-2030)
• Figure 22: Bone Cement Market in APAC (2021-2030)
• Figure 23: Bone Cement Market in APAC by Country (2021-2030)
• Figure 24: Bone Cement Market in China (2021-2030)
• Figure 25: Bone Cement Market in Japan (2021-2030)
• Figure 26: Bone Cement Market in India (2021-2030)
• Figure 27: Bone Cement Market in Australia (2021-2030)
• Figure 28: Bone Cement Market in South Korea (2021-2030)
• Figure 29: Bone Cement Market in Rest of APAC (2021-2030)
• Figure 30: Bone Cement Market in Rest of World (2021-2030)
• Figure 31: Bone Cement Market in RoW by Region (2021-2030)
• Figure 32: Bone Cement Market in Middle East (2021-2030)
• Figure 33: Bone Cement Market in Africa (2021-2030)
• Figure 34: Bone Cement Market in South America (2021-2030)
• Figure 35: Market Drivers
• Figure 36: Market Barriers
• Figure 37: Marker Opportunities
• Figure 38: PORTER'S Five Force Analysis

Bone Cement Market By Product Type (Polymethyl Methacrylate Cement, Glass Polyalkenoate Cement, And Calcium Phosphate Cement), By Joints (Knee, Hip, Shoulder, Spinal, And Others), By Procedure Type (Arthroplasty, Kyphoplasty, And Vertebroplasty) By End User (Hospital, Ambulatory Surgical Centers, And Others) by geography is estimated to register growth at a steady CAGR forecast during 2024-2030 owing to rising prevalence of osteoporosis and joint replacement surgeries

The global bone cement market was valued at USD 894.86 million in 2023, growing at a CAGR of 5.73% during the forecast period from 2024 to 2030 to reach USD 1,247.31 million by 2030. The bone cement market is anticipated to witness prosperity owing to factors such rising prevalence of osteoporosis which leads to more factures. Furthermore, an increase in joint replacement surgeries over the last decade has fueled the market growth of the bone cement industry. An increase in the geriatric population is another factor that will result in appreciable revenue growth in the bone cement market during the forecast period (2024-2030).

Bone Cement Market Dynamics:

One of the major factors which are driving the bone cement market is the rising prevalence of osteoporosis. It is a condition where the bone density reduces thus making the bone weak. Osteoporosis leads to frequent fractures even from minor falls or coughing and sneezing. The increase in the rate of fractures due to the increasing prevalence of osteoporosis has led to a growth in the bone cement market.

The data published by International Osteoporosis Foundation states that due to the condition more than 8.9 million fractures happen annually worldwide. In 2019, across Europe, 32 million individuals aged 50 are estimated to have osteoporosis, equivalent to 5.6% of the total European population aged 50 and over, or approximately 25.5 million women (22.1% of women aged 50 and above) and 6.5 million men (6.6% of men aged 50 and above). Furthermore, as per the same source, by 2050, the worldwide incidence of hip fracture in men is projected to increase by 310% and 240% in women, compared to rates in 1990.

Thus, the increasing incidences of osteoporosis among men and women are increasing the demand for bone cement, which is anticipated to boost the market's growth over the forecast period from 2024-2030.

Moreover, the increasing geriatric population has further driven the need for bone cement market as due to old age, the chances of getting fractures increase many folds due to weakened muscle strength and fragile bone.

According to WHO, by 2050, the world's population of people aged 60 years and older will double to almost 2.1 billion. The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million, thereby fueling the growth of the bone cement market in the forecast period of 2024-2030.

Furthermore, the increase in joint replacement surgeries over the past few decades has increased the demand for the bone cement market. As per the analysis of the Organisation for Economic Cooperation and Development (OECD), on average, hip replacement rates in OECD countries increased by 22% between 2009 and 2019, and knee replacement rates by 35%. This aligns with the rising incidence and prevalence of osteoarthritis, caused by aging populations and growing obesity rates in OECD countries. Thus, driving the growth of the bone cement market in the forecast period of 2024-2030.

COVID-19 has adversely impacted the bone cement market. Due to social distancing, many hospitals were restricted to perform non-elective procedures and surgeries. Furthermore, during the pandemic, the ICU beds were occupied by COVID-19-affected patients. As per a research study published in 2022 titled "A Nation-Wide Review of Elective Surgery and COVID-Surge Capacity" in 2020, there was a 91% reduction from baseline in the number of elective surgeries performed allowing 78% of surgical ICU beds to be available for COVID-19 positive patients in the US.

Moreover, the number of road accidents also decreased across the globe. For instance, in the US, traffic accidents fell by almost half during the two months at the beginning of the COVID-19 pandemic, when residents of most states were forced to stay at home. Therefore, a decrease in road accidents is an indicator of fewer trauma cases. Thus, such instances indicate that the market witnessed slow growth during the pandemic as bone cement is used in the treatment of accident cases. However, with masses being vaccinated and lockdown restrictions being lifted in most parts of the world, the market is expected to witness normalcy.

There are certain restraining factors to the growth of the bone cement market such as unfavorable reimbursement scenarios and the high cost required for launching new products. These above-mentioned factors will act as barriers that will impact the market growth during the forecast period from 2024-2030.

Bone Cement Market Segment Analysis:

Bone Cement Market by Product Type (Polymethyl Methacrylate Cement, Glass Polyalkenoate Cement, and Calcium Phosphate Cement), by Joints (Knee, Hip, Shoulder, Spinal, and Others), by Procedure Type (Arthroplasty, Kyphoplasty, and Vertebroplasty) by End User (Hospital, Ambulatory Surgical Centers, and Others), Geography (North America, Europe, Asia-Pacific, and Rest of the World)

Based on the procedure type segment of the bone cement market, arthroplasty accounted for the largest market share in the year 2023. This can be ascribed to the increase in arthroplasty procedures lately.

Arthroplasty is a surgical procedure to restore the function of a joint. Commonly, the damaged joint is restored by using artificial joints and bone cement. The increase in the prevalence of osteoporosis is one of the main reasons for to increase in arthroplasty surgeries over the years. Thus, by procedure type segment arthroplasty is estimated to be the largest market share.

Due to advancements in arthroplasty, the procedure volume has increased many folds. According to American Joint Replacement Registry (AJRR) 2022 data, almost 2.4 million hip and knee surgeries from over 1150 institutions submitted data, representing an 18.3% increase in total procedural volume compared with that in 2020. This represents a 40% capture rate of all the US total joint arthroplasty (TJA) volume annually. The 2022 AJRR Annual Report reported 2,244,587 primary and revision hip and knee arthroplasties between 2012 and 2020. The majority of the surgeries were primary total knee arthroplasty (54.5%) and primary total hip arthroplasty (38.6%).

All these increases in arthroplasty surgery numbers correspond to the increased market share of the segment, thereby increasing the market growth for the bone cement market.

North America is expected to dominate the overall Bone Cement Market:

Among all the regions, North America is expected to lead in revenue generation in the global bone cement market. The highest growth in the region is registered due to the reasons such as rising cases of bone degenerative diseases, rising cases of trauma, and the presence of major players in the market.

For instance, as per the report published by the Canadian Institute for Health Information in June 2022, in Canada, around 75,073 knee replacements were performed in 2020. It also reported that knee replacement surgery showed an estimated inpatient cost of approximately USD 10,500, which counts up to more than USD 1.4 billion spent annually on this surgery. Therefore, such an instance indicates considerable market growth in this region.

Furthermore, as per the 2019 study quoted in International Osteoporosis Foundation, based on almost 380,000 fractures in female Medicare beneficiaries, 10% had another fracture within 1 year, 18% within 2 years, and 31% within 5 years in the US.

Apart from this, the presence of many key players in the North American region for the bone cement market is also a key factor for the dominance in the market share.

For instance, Stryker is the leading bone cement manufacturer. It is headquartered in the US. The product advancement in the field of bone cement market by a major player like Stryker is growing the market in the North American region. Such as the Antibiotic Simplex bone cement by Stryker.

Therefore, the above-mentioned factors are expected to bolster the growth of the bone cement market in the North American region during the forecast period of 2024-2030.

Bone Cement Market Key Players:

Some of the key market players operating in the bone cement market include Stryker Corporation, Zimmer Biomet, DePuy Synthes (Johnson & Johnson), Smith & Nephew plc, DJO Global, Arthrex Inc, Exactech, Heraeus Holding, Cardinal Health, Tecres S.p.A., Teknimed, Amplitude, Bioceramed, BM Korea, Linacol Medical and others.

Recent Developmental Activities in the Bone Cement Market:

In July 2022, GRAFTYS SA, a recognized specialist in resorbable bone cement for orthopedic surgery, completed an investment round of 2.0 Million Euros with its existing shareholders to accelerate the commercial development and new product launches.

In May 2022, KPower Bhd's, a subsidiary of Granulab (M) Sdn Bhd, launched Malaysia's first halal-certified synthetic bone cement, Prosteomax. Prosteomax is an innovative synthetic calcium phosphate bone cement that has been certified as halal.

Key Takeaways from the Bone Cement Market Report Study

• Market size analysis for current bone cement market size (2023), and market forecast for 5 years (2024-2030)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the bone cement market.
• Top key product developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years
• Key companies dominating the global bone cement market.
• Various opportunities available for the other competitor in the bone cement market space.
• What are the top performing segments in 2023? How these segments will perform in 2030.
• Which are the top-performing regions and countries in the current bone cement market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for bone cement market growth in the coming future?

Target Audience who can be benefited from this Bone Cement Market Report Study

• Bone cement products providers
• Research organizations and consulting companies
• Bone cement-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in bone cement
• Various distribution channels who want to know more about the bone cement market and the latest product innovations in the bone cement market.

Frequently Asked Questions for Bone Cement Market:

1. What is Bone cement?

Bone cement is a mixture of solid and liquid components that hardens to form a bone-like structure to be used in the human body. It is often used in joint replacement surgeries and internal fixation surgeries. Bone cement was originally developed for dental applications.

2. What is the market for global Bone cement?

The global bone cement market was valued at USD 894.86 million in 2023, growing at a CAGR of 5.73% during the forecast period from 2024 to 2030 to reach USD 1,247.31 million by 2030.

3. What are the drivers for the global Bone cement market?

The bone cement market is anticipated to witness prosperity owing to factors such rising prevalence of osteoporosis which leads to more factures. Furthermore, an increase in joint replacement surgeries over the last decade has fueled the market growth of the bone cement industry. An increase in the geriatric population is another factor that will result in appreciable revenue growth in the bone cement market during the forecast period (2024-2030).

4. Who are the key players operating in the global Bone cement market?

Some of the key market players operating in the bone cement market include Stryker Corporation, Zimmer Biomet, DePuy Synthes (Johnson & Johnson), Smith & Nephew plc, DJO Global, Arthrex Inc, Exactech, Heraeus Holding, Cardinal Health, Tecres S.p.A., Teknimed, Amplitude, Bioceramed, BM Korea, Linacol Medical and others.

5. Which region has the highest share in the Bone cement market?

Among all the regions, North America is expected to lead in revenue generation in the global bone cement market. The highest growth in the region is registered due to the reasons such as rising cases of bone degenerative diseases, rising cases of trauma, and the presence of major players in the market in the region.

Table of Contents

1. Bone Cement Market Report Introduction

2. Bone Cement Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment

3. Bone Cement Market Key Factors Analysis

• 3.1. Bone Cement Market Drivers
  • 3.1.1. Rising prevalence of osteoporosis
  • 3.1.2. Increase in joint replacement surgeries
  • 3.1.3. Increase in trauma, accident, and sports-related injuries
  • 3.1.4. Growing geriatric population
• 3.2. Bone Cement Market Restraints and Challenges
  • 3.2.1. Unfavorable reimbursement scenarios
  • 3.2.2. The high cost required for launching a new product
• 3.3. Bone Cement Market Opportunities
  • 3.3.1. Companies adopting various business strategies such as product launches, acquisitions, and partnerships to maintain their market positions

4. Bone Cement Market Porter's Five Forces Analysis

• 4.1. Bargaining Power of Suppliers
• 4.2. Bargaining Power of Consumers
• 4.3. Threat of New Entrants
• 4.4. Threat of Substitutes
• 4.5. Competitive Rivalry

5. COVID-19 Impact Analysis on Bone Cement Market

6. Bone Cement Market Layout

• 6.1. By Product Type
  • 6.1.1. Polymethyl Methacrylate Cement
  • 6.1.2. Glass Polyalkenoate Cement
  • 6.1.3. Calcium Phosphate Cement
• 6.2. By Joints
  • 6.2.1. Knee
  • 6.2.2. Hip
  • 6.2.3. Shoulder
  • 6.2.4. Spine
  • 6.2.5. Others
• 6.3. By Procedure Type
  • 6.3.1. Arthroplasty
  • 6.3.2. Kyphoplasty
  • 6.3.3. Vertebroplasty
• 6.4. By End User
  • 6.4.1. Hospital
  • 6.4.2. Ambulatory Surgical Centers
  • 6.4.3. Others
• 6.5. By Geography
  • 6.5.1. North America
    • 6.5.1.1. United States Bone Cement Market in USD million (2021-2030)
    • 6.5.1.2. Canada Bone Cement Market in USD million (2021-2030)
    • 6.5.1.3. Mexico Bone Cement Market in USD million (2021-2030)
  • 6.5.2. Europe
    • 6.5.2.1. France Bone Cement Market in USD million (2021-2030)
    • 6.5.2.2. Germany Bone Cement Market in USD million (2021-2030)
    • 6.5.2.3. United Kingdom Bone Cement Market in USD million (2021-2030)
    • 6.5.2.4. Italy Bone Cement Market in USD million (2021-2030)
    • 6.5.2.5. Spain Bone Cement Market in USD million (2021-2030)
    • 6.5.2.6. Rest of Europe Bone Cement Market in USD million (2021-2030)
  • 6.5.3. Asia-Pacific
    • 6.5.3.1. China Bone Cement Market in USD million (2021-2030)
    • 6.5.3.2. Japan Bone Cement Market in USD million (2021-2030)
    • 6.5.3.3. India Bone Cement Market in USD million (2021-2030)
    • 6.5.3.4. Australia Bone Cement Market in USD million (2021-2030)
    • 6.5.3.5. South Korea Bone Cement Market in USD million (2021-2030)
    • 6.5.3.6. Rest of the Asia Pacific Bone Cement Market in USD million (2021-2030)
  • 6.5.4. Rest of the World (RoW)
    • 6.5.4.1. Middle East Bone Cement Market in USD million (2021-2030)
    • 6.5.4.2. Africa Bone Cement Market in USD million (2021-2030)
    • 6.5.4.3. South America Bone Cement Market in USD million (2021-2030)

7. Bone Cement Market Company and Product Profiles

• 7.1. Stryker Corporation
  • 7.1.1. Company Overview
  • 7.1.2. Company Snapshot
  • 7.1.3. Financial Overview
  • 7.1.4. Product Listing
  • 7.1.5. Entropy
• 7.2. Zimmer Biomet
  • 7.2.1. Company Overview
  • 7.2.2. Company Snapshot
  • 7.2.3. Financial Overview
  • 7.2.4. Product Listing
  • 7.2.5. Entropy
• 7.3. DePuy Synthes (Johnson & Johnson)
  • 7.3.1. Company Overview
  • 7.3.2. Company Snapshot
  • 7.3.3. Financial Overview
  • 7.3.4. Product Listing
  • 7.3.5. Entropy
• 7.4. Smith & Nephew plc
  • 7.4.1. Company Overview
  • 7.4.2. Company Snapshot
  • 7.4.3. Financial Overview
  • 7.4.4. Product Listing
  • 7.4.5. Entropy
• 7.5. DJO Global
  • 7.5.1. Company Overview
  • 7.5.2. Company Snapshot
  • 7.5.3. Financial Overview
  • 7.5.4. Product Listing
  • 7.5.5. Entropy
• 7.6. Arthrex Inc
  • 7.6.1. Company Overview
  • 7.6.2. Company Snapshot
  • 7.6.3. Financial Overview
  • 7.6.4. Product Listing
  • 7.6.5. Entropy
• 7.7. Exactech
  • 7.7.1. Company Overview
  • 7.7.2. Company Snapshot
  • 7.7.3. Financial Overview
  • 7.7.4. Product Listing
  • 7.7.5. Entropy
• 7.8. Heraeus Holding
  • 7.8.1. Company Overview
  • 7.8.2. Company Snapshot
  • 7.8.3. Financial Overview
  • 7.8.4. Product Listing
  • 7.8.5. Entropy
• 7.9. Cardinal Health
  • 7.9.1. Company Overview
  • 7.9.2. Company Snapshot
  • 7.9.3. Financial Overview
  • 7.9.4. Product Listing
  • 7.9.5. Entropy
• 7.10. Tecres S.p.A
  • 7.10.1. Company Overview
  • 7.10.2. Company Snapshot
  • 7.10.3. Financial Overview
  • 7.10.4. Product Listing
  • 7.10.5. Entropy
• 7.11. Teknimed
  • 7.11.1. Company Overview
  • 7.11.2. Company Snapshot
  • 7.11.3. Financial Overview
  • 7.11.4. Product Listing
  • 7.11.5. Entropy
• 7.12. Amplitude
  • 7.12.1. Company Overview
  • 7.12.2. Company Snapshot
  • 7.12.3. Financial Overview
  • 7.12.4. Product Listing
  • 7.12.5. Entropy
• 7.13. Bioceramed
  • 7.13.1. Company Overview
  • 7.13.2. Company Snapshot
  • 7.13.3. Financial Overview
  • 7.13.4. Product Listing
  • 7.13.5. Entropy
• 7.14. BM Korea
  • 7.14.1. Company Overview
  • 7.14.2. Company Snapshot
  • 7.14.3. Financial Overview
  • 7.14.4. Product Listing
  • 7.14.5. Entropy
• 7.15. Linacol Medical
  • 7.15.1. Company Overview
  • 7.15.2. Company Snapshot
  • 7.15.3. Financial Overview
  • 7.15.4. Product Listing
  • 7.15.5. Entropy

8. KOL Views

9. Project Approach

10. About DelveInsight

11. Disclaimer & Contact Us